DGS Capital Management LLC Has $466,000 Holdings in Sanofi (NASDAQ:SNY)

DGS Capital Management LLC trimmed its holdings in shares of Sanofi (NASDAQ:SNY) by 5.9% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 9,593 shares of the company’s stock after selling 601 shares during the quarter. DGS Capital Management LLC’s holdings in Sanofi were worth $466,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of SNY. Boston Partners grew its holdings in Sanofi by 1.9% during the fourth quarter. Boston Partners now owns 13,032,746 shares of the company’s stock valued at $648,617,000 after purchasing an additional 245,682 shares during the last quarter. Morgan Stanley raised its holdings in Sanofi by 4.6% in the 3rd quarter. Morgan Stanley now owns 7,322,806 shares of the company’s stock worth $392,796,000 after acquiring an additional 323,968 shares during the period. Brandes Investment Partners LP lifted its position in Sanofi by 64.6% during the 4th quarter. Brandes Investment Partners LP now owns 1,770,572 shares of the company’s stock worth $88,051,000 after acquiring an additional 694,957 shares during the last quarter. Morningstar Investment Services LLC boosted its holdings in Sanofi by 99.5% during the fourth quarter. Morningstar Investment Services LLC now owns 1,486,949 shares of the company’s stock valued at $73,425,000 after acquiring an additional 741,456 shares during the period. Finally, American Century Companies Inc. grew its position in shares of Sanofi by 1.0% in the third quarter. American Century Companies Inc. now owns 1,472,190 shares of the company’s stock valued at $78,968,000 after purchasing an additional 15,154 shares during the last quarter. 10.04% of the stock is currently owned by institutional investors.

Sanofi Stock Down 0.5 %

Shares of SNY stock opened at $48.08 on Friday. Sanofi has a 12 month low of $42.63 and a 12 month high of $55.72. The company has a quick ratio of 0.87, a current ratio of 1.27 and a debt-to-equity ratio of 0.19. The firm has a market cap of $121.77 billion, a PE ratio of 24.16, a price-to-earnings-growth ratio of 1.50 and a beta of 0.60. The stock has a 50 day moving average of $48.59 and a 200-day moving average of $48.54.

Sanofi (NASDAQ:SNY) last released its earnings results on Thursday, April 25th. The company reported $0.96 EPS for the quarter, meeting the consensus estimate of $0.96. Sanofi had a net margin of 10.52% and a return on equity of 26.25%. The firm had revenue of $11.36 billion during the quarter, compared to analysts’ expectations of $11.75 billion. On average, equities analysts predict that Sanofi will post 4.13 EPS for the current year.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.